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Abstract
Background: The objective of this study was to acquire a broader, more comprehensive picture of the
transcriptional changes in the L. Thoracis muscle (LT) and subcutaneous fat (SF) of lambs supplemented with
vitamin E. Furthermore, we aimed to identify novel genes involved in the metabolism of vitamin E that might
also be involved in meat quality. In the first treatment, seven lambs were fed a basal concentrate from weaning
to slaughter (CON). In the second treatment, seven lambs received basal concentrate from weaning to 4.71 ± 2.
62 days and thereafter concentrate supplemented with 500 mg dl-α-tocopheryl acetate/kg (VE) during the last 33.
28 ± 1.07 days before slaughter.
Results: The addition of vitamin E to the diet increased the α-tocopherol muscle content and drastically diminished
the lipid oxidation of meat. Gene expression profiles for treatments VE and CON were clearly separated from each
other in the LT and SF. Vitamin E supplementation had a dramatic effect on subcutaneous fat gene expression,
showing general up-regulation of significant genes, compared to CON treatment. In LT, vitamin E supplementation
caused down-regulation of genes related to intracellular signaling cascade. Functional analysis of SF showed that
vitamin E supplementation caused up-regulation of the lipid biosynthesis process, cholesterol, and sterol and
steroid biosynthesis, and it down-regulated genes related to the stress response.
Conclusions: Different gene expression patterns were found between the SF and LT, suggesting tissue specific
responses to vitamin E supplementation. Our study enabled us to identify novel genes and metabolic pathways
related to vitamin E metabolism that might be implicated in meat quality. Further exploration of these genes and
vitamin E could lead to a better understanding of how vitamin E affects the oxidative process that occurs in
manufactured meat products.
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Background
Vitamin E is a lipid-soluble essential component of
human and animal diets due to its powerful antioxidant
activity. There are eight different isoforms of vitamin E,
and the most active isoform for cell protection appears
to be α-tocopherol [1]. Alpha-tocopherol is a cell signal-
ing molecule involved in a broad range of effects on
cellular systems [2] and specific regulation of gene ex-
pression [2–6]; therefore, α-tocopherol can influence a
number of biological functions by regulating cell signal-
ing at both the mRNA and microRNA (miRNA) levels
[7]. So far, the impact and beneficial effects of vitamin E
in the prevention of chronic diseases have been mainly
associated with its antioxidant properties [8].
Vitamin E is extensively used in animal diets as an
antioxidant supplement. Feeding strategy is an important
tool to manipulate intramuscular α-tocopherol content
in animals. An increase in α-tocopherol intake can be
achieved through grazing systems [9] or by feeding ani-
mals with concentrate supplemented with α-tocopherol,
which can be used as an effective method to reduce the
oxidative processes reported in meat products [10, 11].
During oxidative processes, the muscle haeminic pig-
ment changes from red oxymyoglobin to brown metmyo-
globin, giving the meat an undesirable brownish color [9].
Moreover, lipid oxidation results in the production of free
radicals, which are linked to the formation of off-flavors
and odors, a reduction in polyunsaturated fatty acids and
the production of undesirable compounds, such as poten-
tially toxic peroxides and aldehydes [12]. All of these mod-
ifications cause decreases in the freshness and quality of
meat and lower consumer acceptance, resulting in consid-
erable economic loss for the meat industry.
So far, efforts to discover the genes and metabolic
pathways involved in vitamin E metabolism have mainly
focused on rodents. These studies have reported im-
portant long-term effects of vitamin E deficiency on
liver gene expression, up-regulation of genes involved
in cholesterol synthesis and steroidogenesis, lipid uptake,
and anti-oxidative mechanisms [3, 13]. In addition,
vitamin E in the rat brain affected genes associated with
hormones, nerve growth, apoptosis, dopaminergic neuro-
transmission, and clearance of amyloid-α [14]. Further-
more, genes encoding for muscle structure and extra
cellular matrix and those involved in anti-oxidative and
anti-inflammatory processes were up-regulated in rat skel-
etal muscle in response to vitamin E deficiency [15].
Although nutritional science has embraced the tools
of genomics, including cDNA arrays in rodent models,
few attempts at large-scale or global evaluation of nu-
tritional gene regulation have mainly used rodents as a
model. Only a small number of genes are currently
known to be related to vitamin E metabolism in muscle or
fat. In the last few years, several studies have explored the
transcriptomic adaptations of skeletal muscle in response
to different nutrition variables in ruminants [16–19]. Data
from these studies have allowed scientists to identify the
biochemical mechanisms that could be associated with
key physiological processes in animals and to define spe-
cific markers for evaluating meat quality.
A better understanding of the genes and metabolic
pathways associated with vitamin E metabolism is crit-
ical for identifying the key physiological processes asso-
ciated with vitamin E content, oxidative stress and other
metabolic pathways associated with meat quality. The
main effect of vitamin E on meat is to change the lipid
oxidation and thus to increase shelf-life of meat. Because
lipid oxidation depends mainly on enzyme activity, post-
transcriptional and post-translational changes are pro-
cesses implicated in the shelf-life of meat. However, the
identification of genes related to vitamin E content
would be a good starting point for candidate gene selec-
tion and single nucleotide polymorphism (SNP) associ-
ation studies with variations in vitamin E content and
therefore implicated in meat quality. Furthermore, non-
antioxidant roles of vitamin E, serving as a regulator of
gene/protein, have been described. In this sense, tran-
scriptomic analysis of skeletal muscle could identify
metabolic pathways modified by vitamin E that could
influence meat traits.
Therefore, the main objective of this study was to inves-
tigate transcriptional changes in the L. Thoracis muscle
(LT) and subcutaneous fat (SF) of lambs supplemented
with vitamin E using the Affymetrix Ovine Gene 1.1 ST
whole-genome array. Furthermore, we aimed to identify
novel genes that could play important roles in the metab-
olism of vitamin E and that might be associated with meat
quality traits.
Results
Alpha-tocopherol muscle content, intramuscular fat,
TBARS and metmyoglobin formation
Significant differences in weaning weight and slaughter
age (SA), and average daily gain (ADG), from birth to
weaning and from birth to slaughter, were found
between treatments (Table 1). Animals from the CON
group were younger at slaughter (P < 0.05). In addition,
these animals had greater ADG from birth to weaning
(P < 0.01) and from birth to slaughter (P < 0.05). During
the experimental period, the ADG from weaning to
slaughter was not significant between treatments. Aver-
age daily gain from birth to slaughter and SA were
highly correlated between them (r2 = -0.90; P < 0.01).
The results of α-tocopherol content, intramuscular fat
(IMF) content, thiobarbituric acid-reactive substances
(TBARS) and metmyoglobin (MMb) formation in the LT
muscle for each treatment are shown in Table 1. Our re-
sults showed that the content of α-tocopherol in the
González-Calvo et al. BMC Genomics  (2017) 18:92 Page 2 of 19
muscle was significantly higher in lambs that received a
basal concentrate supplemented with dl-α-tocopheryl
acetate (VE), while lambs fed a basal concentrate (CON)
showed higher values of TBARS (mg of malonaldehyde
per kg of L. Thoracis) (P < 0.05). Furthermore, metmyo-
globin formation was significantly lower in VE lambs,
compared to the CON group (P < 0.05). The K/S572/525
ratio decreased when the metmyoglobin content in-
creased. Intramuscular fat (IMF) content was not differ-
ent between the treatments (P > 0.05).
Microarray gene expression results
Identification and classification of differentially expressed
genes by microarray analysis in LT and SF
Significance analysis of microarray (SAM) was performed
to compare the VE treatment with CON. SAM identified
a total of 29 genes with a false discovery rate (FDR) =
0.008, 26 down- regulated and 3 up-regulated genes
(Table 2). The results of SAM regarding LT muscle are
shown in Fig. 1.
Regarding subcutaneous fat, when VE treatment was
compared with the CON group, SAM identified a total
of 330 genes with a FDR < 0.001. Among these genes,
295 were up-regulated, and 35 were down-regulated.
The results of the top 50 genes identified with SAM for
SF are shown in Table 3. In Additional file 1: Table S1
all of the significant genes in SF are ranked according
to their fold change (FC). Notably, H1F0 gene was
found to be significantly down-regulated in VE lambs
in both tissues.
Treatment-dependent multivariate analysis results of gene
expression
In the LT muscle, principal component analysis (PCA)
of the complete set of 32 genes identified by SAM
showed that the first 2 PCs covered 39.7% of the ob-
served variance in the sample set (Fig. 2a). The PCA
score plot revealed differences corresponding to lambs
fed with the two different treatments. The ellipse corre-
sponding to CON was clearly separated from the VE
treatment. Partial least squares-discriminate analysis
(PLS-DA) showed a clear separation of the two groups
(Fig. 2b). In addition, PLS-DA allowed for the identifica-
tion of the genes that were most important for the sep-
aration observed in the score plots. DEF8 gene showed
the highest score, followed by ASPN and AKR7A2
(Fig. 2c). Moreover, we investigated trends or patterns in
gene expression changes (Fig. 2d). For example, ABCC4,
DEPTOR, IGFR1, MYLK2 and ACAT1 were positively cor-
related with each other in the two treatments, showing a
down- and up-regulation in the VE and CON treatments,
respectively. In contrast, they were negatively correlated
with SAT1, ASPN, or LRRTM2. These genes, which are
either positively or negatively correlated with each other,
appeared to play an important role in light of the PCA
and PLS-DA cluster analysis.
Multivariate analysis results from subcutaneous fat
were used to cluster the samples based on gene expres-
sion profiles of animals fed two different diets: CON and
VE. The PCA of the complete set of 330 genes identified
by SAM showed that the first 2 PCs covered 68% of the
observed variance of the sample set (Fig. 3a). The figure
shows the score plot of the two first principal compo-
nents extracted in this study. PLS-DA showed that the
VE and CON groups were clearly separate from each
other. (Fig. 3b). In addition, PLS-DA allowed for the
identification of the most important genes contributing
to the separation observed in the score plots, and
ALG11 had the highest score, followed by SRPBR and
PPX47.
Moreover, we investigated patterns in gene expression
changes in subcutaneous fat (Fig. 3d). For example, the
gene expressions of ALG11, SRPBR, and PPX47 were
positively correlated with each other, being up-regulated
in VE treatment.
Hierarchical clustering analysis (HCA)
HCA was performed using the significant genes obtained
by SAM for both contrasts. The results of HCA for LT
muscle are presented in Fig. 4a. The expression profile
of these genes was able to cluster and to classify cor-
rectly the samples within their corresponding groups.
Table 1 Effect of the dietary treatment on slaughter age and
weight, growth rate, alpha-tocopherol muscle content, intramuscular
fat, TBARS and metmyoglobin formation
Treatment1
CON VE SE P-value
Performance
Weaning Weight (kg) 15.29 11.59 0.5246 **
Slaughter Age (days) 72.28 86.28 3.59 *
Slaughter Weight (kg) 23.20 22.71 0.45 ns
Average Daily Gain (g/day)
- From birth to weaning 281.43 203.71 11.10 **
- Experimental period2 337.86 276.57 22.70 ns
- From birth to slaughter 278.14 230.57 12.25 *
L. Thoracis muscle
α-Tocopherol, mg/kg muscle 0.13 2.26 0.07 ***
IMF (% fresh matter) 2.03 1.68 0.25 ns
TBARS (7 d)3 1.62 0.07 0.17 ***
K/S572/525 (7 d)
4 0.93 1.06 0.03 *
1CON: commercial concentrate without VE supplement; VE: VE concentrate for
33.3 ± 1.07 days before slaughter. Means within a row with different
superscripts differ (P < 0.05); SE: standard error; ns: not significant; ***P < 0.001;
**P < 0.01;*P < 0.05; 2Experimental period started at 48 d old. 3TBARS: mg of
malonaldehyde per kg of L. Thoracis muscle at 7 days of display; 4K/S572/525:
ratio of metmyoglobin formation of L. Thoracis muscle at 7 days of display
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The heatmap shows the presence of 2 different clusters
containing different genes. The responses of each vari-
able to the two different treatments are indicated with
changes in the color intensity on the heatmap. The VE
and CON groups showed very different gene expression
patterns. For instance, LRRTM2, ASPN and SAT1 were
up-regulated in the VE group. Furthermore, a second
cluster including the remainder of the genes was found
to be down-regulated in the VE group. These two clus-
ters distinguished the VE group from the CON group.
These genes are involved in different metabolic
processes.
Regarding subcutaneous fat, the results of clustering
analysis of top 50 genes are presented in Fig 4b. Ana-
lyzing the heatmap, it can be observed that the CON
group showed very different gene expression patterns
from the VE group. There is a general down-regulation
of gene expression in the CON group and an up-
regulation of gene expression in the VE group. The
results of clustering analysis of the total 330 genes in
subcutaneous fat were similar to the 50 genes analysis
results, but one VE animal was clustered in the CON
group (Additional file 2: Figure S1). More specifically,
34 genes were down- regulated in the VE group (SOD3,
CLEC3B, METTL7A, IER3, PLK2, CLEC1A, HSPA1A,
TNFSF10, MERTK, MLLT3, TPPP2, HMGB2, PECAM1,
IFITM3, H1F0, HMG20B, GALK1, NFIL3, CDH5, ERG,
CEBPA, ANKRD44, HCST, UACA, IFITM1, RPL10,
PID1, LUC7L3, H3F3A, AMOTL2, PSIP1, RPL17,
TRA2A, and RPS259).
Functional clustering annotation
In the LT muscle, the results of Database for Annota-
tion, Visualization and Integrated Discovery (DAVID)
functional annotation clustering (FAC), including the 29
significant genes in the VE-CON contrast, showed that 4
genes from the “intracellular signaling cascade” (IGF1R,
DEF8, AKAP7 and CISH) had the most enrichment and
were all down-regulated in the VE treatment (Additional
file 3: Table S2). However, the confident enrichment
scores were less than 1.3 in both cases.
In subcutaneous fat, the results of DAVID FAC of 330
significant genes in the VE-CON contrast, revealed that
the most significantly enriched cluster was “lipid biosyn-
thesis process”, (enrichment score of 5.38) with a total of
20 genes involved (PGAP3, EBP, CRLS1, MVD, CYP51A1,
GNE, HMGCS1, DPAGT1, LSS, SIGMAR1, LPCAT3,
FDFT1, DOLK, PIGM, SQLE, DHCR7, AGPAT9, LTA4H,
PCYT2 and HSD17B7), all of them up-regulated in the VE
group compared to the CON group. Many of these genes
play roles in the cholesterol, sterol and steroid biosyn-
thesis. In Table 4, the DAVID FAC results of the 330 genes
in the VE-CON contrast are shown.
Validation of microarrays results using qPCR
Thirteen genes were selected to validate the microarray
results by quantitative real-time PCR (qPCR). The gene
set included 4 genes in muscle and 9 genes in subcuta-
neous fat. In LT muscle, the genes were selected because
they were significant differentially expressed between the
Table 2 The significant features identified by SAM in VE vs. CON
contrast in L. Thoracis muscle
Gene
symbol
Gene name q value FC
AKR7A2 aldo-keto reductase family 7, member A2 0 −1.25
DEF8 differentially expressed in FDCP 8
homolog
0 −1.20
ASPN asporin 0 1.65
PPP6R3 Protein Phosphatase 6, Regulatory
Subunit 3
0.00295 −1.14
SAT1 spermidine/spermine N1-acetyltransferase
1
0.00295 1.55
KLHL33 kelch-like 33 0.00442 −1.30
ABCC4 ATP-binding cassette, sub-family C (CFTR/
MRP), member 4
0.00925 −1.22
CISH cytokine inducible SH2-containing
protein
0.00954 −2.05
AKAP7 A kinase (PRKA) anchor protein 7 0.00954 −1.53
ACACB acetyl-Coenzyme A carboxylase beta 0.00954 −1.41
MAFB v-maf musculoaponeurotic fibrosarcoma
oncogene homolog B
0.00954 −1.37
H1F0 H1 histone family, member 0 0.00954 −1.32
MYLK2 myosin light chain kinase 2 0.00954 −1.31
DUSP26 dual specificity phosphatase 26 (putative) 0.00954 −1.30
RSC1A1 regulatory solute carrier protein, family 1,
member 1
0.00954 −1.28
FHL3 four and a half LIM domains 3 0.00954 −1.26
ACAT1 acetyl-Coenzyme A acetyltransferase 1 0.00954 −1.25
FAM151A family with sequence similarity 151,
member A
0.00954 −1.23
KIAA0430 KIAA0430 0.00954 −1.22
ZNF777 zinc finger protein 777 0.00954 −1.20
DEPTOR DEP Domain Containing MTOR-
Interacting Protein
0.00954 −1.19
LRRTM2 leucine rich repeat transmembrane
neuronal 2
0.00954 1.26
DDX39B DEAD (Asp-Glu-Ala-Asp) Box Polypeptide
39B
0.00974 −1.43
PGLS 6-phosphogluconolactonase 0.0097 −1.21
BTNL9 butyrophilin-like 9 0.01006 −1.39
FBXL4 F-box and leucine-rich repeat protein 4 0.01006 −1.38
IGF1R insulin-like growth factor 1 receptor 0.01006 −1.17
ST6GALNAC6 ST6-N-acetylgalactosaminide alpha-2,6-
sialyltransferase 6
0.01006 1.14
ANAPC16 chromosome 10 open reading frame 104 0.01006 1.25
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Fig. 1 Significant features identified by SAM in a VE-CON contrast in LT, and b VE-CON contrast in SF. The green circles represent features that
exceed the specified threshold
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VE and CON treatments (CISH, ABCC4, ACAT1 and
IGF1R). In SF, the significant genes in the VE-CON con-
trast (LDLR, SOD3, SQLE, SREBF1, MTTL1, HAX1,
HMGB2, HSPB8 and IER3) were selected. Although the
magnitude of FC obtained by microarray and qPCR
was slightly different in some instances, the qPCR re-
sults demonstrated a similar trend compared with the
microarray results of these 13 genes, demonstrating
the reliability of microarray analysis (Pearson’s correl-
ation coefficient 0.99, P = 0.008 for LT muscle and
0.99, P < 0.001 for SF) (Table 5).
Discussion
The aim of the present study was to assess the effects of
adding VE to the fattening concentrate, fed between
weaning and slaughter, on the transcriptional changes in
the LT and SF. The experimental period ended when the
lambs reached the target slaughter LW (22–24 kg),
according to the specifications of Ternasco de Aragón
Protected Geographical Indication (Regulation (EC) No.
1107/96). The light lamb production is based on two
periods: suckling and fattening. The suckling period is
usually limited by the time, usually lasting approximately
45 d (in the present study, it was 48 d), while the
Table 3 Top 50 genes identify with SAM in VE vs. CON contrast
in subcutaneous fat
Gene symbol Gene Name q value FC
DDX47 DEAD (Asp-Glu-Ala-Asp) box
polypeptide 47
0 1.50
ALG11 UTP14, U3 small nucleolar
ribonucleoprotein, homolog C
0 1.67
SRPRB signal recognition particle receptor,
B subunit
0 2.30
TTC37 tetratricopeptide repeat domain 37 1.07E-05 1.32
RRAGA Ras-related GTP binding A 1.07E-05 1.40
LRRC59 leucine rich repeat containing 59 1.07E-05 1.47
RASSF8 Ras association domain family
(N-terminal) member 8
1.07E-05 1.55
ELP3 elongation protein 3 homolog 1.07E-05 1.56
SEC23IP SEC23 interacting protein 1.07E-05 1.61
TMEM181 transmembrane protein 181 1.07E-05 1.65
CAND1 cullin-associated and neddylation-
dissociated 1
1.53E-05 1.39
PIGM phosphatidylinositol glycan anchor
biosynthesis, class M
1.53E-05 1.42
TMEM203 transmembrane protein 203 1.53E-05 1.52
ABCE1 similar to ATP-binding cassette,
sub-family E, member 1
1.53E-05 1.69
WDR55 WD repeat domain 55 2.01E-05 1.31
SLC35A4 solute carrier family 35, member A4 2.01E-05 1.32
ARPC5 actin related protein 2/3 complex,
subunit 5, 16 kDa
2.04E-05 1.29
MINPP1 multiple inositol polyphosphate
histidine phosphatase, 1
2.04E-05 1.38
RER1 RER1 retention in endoplasmic
reticulum 1 homolog
2.04E-05 1.46
TIMM22 translocase of inner mitochondrial
membrane 22 homolog
2.04E-05 1.56
EXTL3 exostoses (multiple)-like 3 2.04E-05 1.63
GMPS guanine monphosphate synthetase 2.23E-05 1.45
SLC39A7 solute carrier family 39 (zinc
transporter), member 7
2.23E-05 1.49
MARS methionyl-tRNA synthetase 2.23E-05 1.56
RAB22A RAB22A, member RAS oncogene
family
2.47E-05 1.32
ADSS adenylosuccinate synthase 2.47E-05 1.58
IER3 immediate early response 3 2.81E-05 −2.06
RNF121 ring finger protein 121 2.81E-05 1.34
DNAJC5 DnaJ (Hsp40) homolog, subfamily C,
member 5
2.81E-05 1.34
NUDT9 nudix (nucleoside diphosphate
linked moiety X)-type motif 9
2.81E-05 1.36
WAPAL wings apart-like homolog 2.81E-05 1.38
FBXO28 F-box protein 28 2.81E-05 1.41
AP1S1 adaptor-related protein complex 1,
sigma 1 subunit
2.81E-05 1.43
Table 3 Top 50 genes identify with SAM in VE vs. CON contrast
in subcutaneous fat (Continued)
CNPY4 canopy 4 homolog 2.81E-05 1.48
KIAA1274 Phosphatase Domain Containing,
Paladin 1
2.81E-05 1.48
AKAP10 A kinase (PRKA) anchor protein 10 2.81E-05 1.48
HNRNPH2 ribosomal protein L36a pseudogene
51
2.81E-05 1.52
MCU mitochondrial calcium uniporter 2.81E-05 1.53
SLC39A3 solute carrier family 39 (zinc
transporter), member 3
2.81E-05 1.57
EMC8 ER membrane protein complex
subunit 8
2.81E-05 1.59
PROSC proline synthetase co-transcribed
homolog
2.81E-05 1.62
ABCF3 ATP-binding cassette, sub-family F
(GCN20), member 3
2.81E-05 1.65
C5H22orf28 chromosome 5 open reading frame,
human C22orf28
2.81E-05 1.67
PINX1 PIN2-interacting protein 1 2.81E-05 1.69
ADPGK ADP-dependent glucokinase 2.81E-05 1.75
CERS6 ceramide synthase 6 2.81E-05 1.76
DOLPP1 dolichyl pyrophosphate phosphatase 1 2.81E-05 1.79
DOLK dolichol kinase 2.81E-05 1.86
RPS4Y1 ribosomal protein S4, Y-linked 1 2.81E-05 1.90
TIMM8A translocase of inner mitochondrial
membrane 8 homolog A
2.81E-05 2.27
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fattening period is limited by the weight (22–24 kg LW).
Thus, lambs with high ADG during lactation period
spent fewer days in the fattening period than those with
low ADG. To be able to evaluate the potential effects of
the inclusion of VE on the transcriptome of the L. Thor-
acis muscle and subcutaneous fat, we planned to feed at
least 30 days of VE concentrate. According to Ripoll et
al. [11], supplementation with VE for 30 days was found
to increase noticeably concentration of the α-tocopherol
content in muscle. In the present study, the ADG during
the experimental period was not different, however dur-
ing the suckling period it was lower in VE treatment (p <
0.01; Table 1). This implies that the lambs of the VE treat-
ment during the suckling period presented lower growth
Fig. 2 Multivariate analysis based on gene expression profile data in LT muscle. a Principal component analysis (PCA) score plots distinguishing
between the LT muscle of lambs fed concentrate (triangle), and supplemented with vitamin E in the treatment, (+). b Partial least squares-
discriminant analysis (PLC-DA) based on gene expression profile data. c Important features identified by PLS-DA. The top 15 genes are ranked by
VIP scores. The colored boxes on the right indicate the relative expression of the corresponding gene in each group under study. d A bar graph
showing the top 25 genes correlating with diet (CON, VE). Variables with the same distance from 0 with similar positions are positively correlated.
Those with the opposite direction are negatively correlated. The light blue bars indicate genes showing a negative correlation, and the light pink
bars indicate those with a positive correlation with the given pattern of change of treatment
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compared to the CON group and needed more days to
reach the target weight. Moreover, there was a strong cor-
relation between ADG from birth to slaughter and SA (r2
=−0.9). Therefore, to overcome this unbalance between
treatments ADG values were included as covariates in the
statistical model used to validate gene expression differ-
ences by qPCR, thus avoiding estimation biases. We ana-
lyzed LT muscle and SF because meat cuts for human
consumption include both intramuscular and subcutane-
ous fat [20], constituting the total amount of meat fat
Fig. 3 Multivariate analysis based on gene expression profile data in subcutaneous fat. a Principal component analysis (PCA) score plots
distinguishing between the subcutaneous fat of lambs fed concentrate (triangle), and supplemented with vitamin E in the treatment (+).
b Partial least squares-discriminant analysis (PLC-DA) based on gene expression profile data. c Important features identified by PLS-DA. The
top 15 genes are ranked by VIP scores. The colored boxes on the right indicate the relative expression of the corresponding gene in each
group under study. d A bar graph showing the top 25 genes correlating with treatment (CON, VE). Variables with the same distance from 0
with similar positions are positively correlated. Those with the opposite direction are negatively correlated The light pink bars indicate genes
with a positive correlation with the given pattern of change of treatment
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Fig. 4 Hierarchical clustering analysis of gene expression in a) the L. Thoracis muscle, b) subcutaneous fat tissue of lambs receiving different treatments
(CON and VE), using the most significant genes of each contrast. Cells are colored based on the signal intensity measured. Dark brown represents high
gene expression levels, blue indicates low signal intensity, and gray indicates the intermediate level (see color scale above the heatmap)
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Table 4 DAVID Functional Annotation Clustering of SAM genes in VE vs. CON subcutaneous fat
Annotation Cluster 1
Enrichment Score: 5.82
Category Term Count % P Value Genes
GOTERM_BP_FAT GO:0016126 ~ sterol biosynthetic process 9 3.26 6.03E-08 EBP, MVD, CYP51A1, SQLE, DHCR7, HMGCS1, LSS,
SIGMAR1, FDFT1
GOTERM_BP_FAT GO:0016125 ~ sterol metabolic process 12 4.35 6.02E-07 SREBF1, EBP, LDLR, MVD, CYP51A1, SQLE, DHCR7,
INSIG1, HMGCS1, LSS, SIGMAR1, FDFT1
GOTERM_BP_FAT GO:0008610 ~ lipid biosynthetic process 20 7.25 1.04E-06 PGAP3, EBP, CRLS1, MVD, CYP51A1, GNE, HMGCS1,
DPAGT1, LSS, SIGMAR1, LPCAT3, FDFT1, DOLK, PIGM,
SQLE, DHCR7, AGPAT9, LTA4H, PCYT2, HSD17B7
GOTERM_BP_FAT GO:0008203 ~ cholesterol metabolic
process
11 3.99 2.01E-06 SREBF1, EBP, LDLR, MVD, CYP51A1, SQLE, DHCR7,
INSIG1, HMGCS1, LSS, FDFT1
GOTERM_BP_FAT GO:0006695 ~ cholesterol biosynthetic
process
7 2.54 2.73E-06 EBP, MVD, CYP51A1, DHCR7, HMGCS1, LSS, FDFT1
GOTERM_BP_FAT GO:0006694 ~ steroid biosynthetic process 10 3.62 8.22E-06 EBP, MVD, CYP51A1, SQLE, DHCR7, HMGCS1, LSS,
SIGMAR1, HSD17B7, FDFT1
GOTERM_BP_FAT GO:0008202 ~ steroid metabolic process 13 4.71 9.78E-05 SREBF1, EBP, MVD, LDLR, CYP51A1, HMGCS1, LSS,
SIGMAR1, FDFT1, SQLE, DHCR7, INSIG1, HSD17B7
Annotation Cluster 2
Enrichment Score: 3.59
GOTERM_BP_FAT GO:0007005 ~mitochondrion organization 13 4.71 2.11E-06 NDUFAF4, CAV2, DNM1L, MTX2, TOMM40, TIMM44,
TIMM8A, TRNT1, GFM2, MRPL12, FXC1, PTCD2,
DNAJA3
GOTERM_BP_FAT GO:0015031 ~ protein transport 29 10.51 3.19E-05 SNX19, MTX2, SNX4, RAB1A, COPB2, AP1S1, FXC1,
VPS4A, NUP35, SEC23IP, ZW10, RAB2B, SRP54, VPS45,
TOMM40, NUP85, AP4S1, TIMM44, TIMM8A, TIMM22,
TRNT1, YWHAG, PLEKHA8, RAB22A, KPNA6, NOP58,
NUP43, KPNA1, SNX11
GOTERM_BP_FAT GO:0045184 ~ establishment of protein
localization
29 10.51 3.75E-05 SNX19, MTX2, SNX4, RAB1A, COPB2, AP1S1, FXC1,
VPS4A, NUP35, SEC23IP, ZW10, RAB2B, SRP54, VPS45,
TOMM40, NUP85, AP4S1, TIMM44, TIMM8A, TIMM22,
TRNT1, YWHAG, PLEKHA8, RAB22A, KPNA6, NOP58,
NUP43, KPNA1, SNX11
GOTERM_BP_FAT GO:0008104 ~ protein localization 31 11.23 6.84E-05 SNX19, MTX2, SNX4, AKAP10, RAB1A, COPB2, AP1S1,
FXC1, PIKFYVE, VPS4A, NUP35, SEC23IP, ZW10, RAB2B,
SRP54, VPS45, TOMM40, NUP85, AP4S1, TIMM44,
TIMM8A, TIMM22, TRNT1, YWHAG, PLEKHA8, RAB22A,
KPNA6, NOP58, NUP43, KPNA1, SNX11
GOTERM_BP_FAT GO:0033365 ~ protein localization in
organelle
11 3.99 1.17E-04 TRNT1, SRP54, MTX2, FXC1, PIKFYVE, KPNA6, TOMM40,
NOP58, TIMM44, KPNA1, TIMM8A
GOTERM_BP_FAT GO:0006626 ~ protein targeting to
mitochondrion
6 2.17 1.89E-04 TRNT1, MTX2, FXC1, TOMM40, TIMM44, TIMM8A
GOTERM_BP_FAT GO:0070585 ~ protein localization in
mitochondrion
6 2.17 1.89E-04 TRNT1, MTX2, FXC1, TOMM40, TIMM44, TIMM8A
GOTERM_BP_FAT GO:0034613 ~ cellular protein localization 18 6.52 3.25E-04 SRP54, VPS45, MTX2, TOMM40, AP4S1, TIMM44,
TIMM8A, TRNT1, COPB2, YWHAG, AP1S1, FXC1,
PIKFYVE, KPNA6, NOP58, SEC23IP, KPNA1, ZW10
GOTERM_BP_FAT GO:0070727 ~ cellular macromolecule
localization
18 6.52 3.51E-04 SRP54, VPS45, MTX2, TOMM40, AP4S1, TIMM44,
TIMM8A, TRNT1, COPB2, YWHAG, AP1S1, FXC1,
PIKFYVE, KPNA6, NOP58, SEC23IP, KPNA1, ZW10
Annotation Cluster 3
Enrichment Score: 3.00
GOTERM_BP_FAT GO:0008299 ~ isoprenoid biosynthetic
process
5 1.81 2.51E-04 MVD, HMGCS1, DPAGT1, FDFT1, DOLK
GOTERM_BP_FAT GO:0006720 ~ isoprenoid metabolic
process
6 2.17 6.48E-04 RDH11, MVD, HMGCS1, DPAGT1, FDFT1, DOLK
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purchased at retail. The results related to the content of α-
tocopherol in the muscle and TBARS confirm what was
planned in the methodology. Vitamin E has been success-
fully used to increase the muscle α-tocopherol and to re-
duce lipid oxidation in beef and chicken meat [21]. In this
study, as expected, there were significant differences be-
tween both diets in the α-tocopherol content, lipid
oxidation and MMb formation in the LT muscle, as previ-
ously found by Ripoll et al. [11]. Moreover, TBARS values
were lower in VE lambs which showed that the lipid oxi-
dation process was slower in animals fed this type of diet.
In the present study, we used microarray technology to
study changes in gene expression profiles in LT muscle
and SF in response to vitamin E supplementation in
lambs. Our results, showed that vitamin E supplementa-
tion caused different responses in gene expression in LT
muscle and SF, suggesting a specific response of tissue to
vitamin E supplementation. In our study, we did not
measure the concentration of VE in the SF, however the
gene expression results might be related to the greater
α-tocopherol accumulation in adipose tissues than in
skeletal muscles [22, 23].
It has been reported that α-tocopherol can influence a
number of biological functions by regulating cell signaling
at both the mRNA and miRNA levels [7]. Indeed, our re-
sults showed that vitamin E supplementation affected the
Table 4 DAVID Functional Annotation Clustering of SAM genes in VE vs. CON subcutaneous fat (Continued)
GOTERM_BP_FAT GO:0016090 ~ prenol metabolic process 3 1.09 2.46E-3 DPAGT1, FDFT1, DOLK
GOTERM_BP_FAT GO:0016093 ~ polyprenol metabolic
process
3 1.09 2.46E-3 DPAGT1, FDFT1, DOLK
Annotation Cluster 4
Enrichment Score: 1.72
GOTERM_BP_FAT GO:0034660 ~ ncRNA metabolic process 13 4.71 3.28E-04 GARS, EPRS, IARS, TRNT1, WDR55, NOLC1, METTL1,
ADAT2, NOP58, ALG11, NSUN2, FTSJ2, MARS
GOTERM_BP_FAT GO:0034470 ~ ncRNA processing 9 3.26 1.03E-2 TRNT1, WDR55, NOLC1, METTL1, ADAT2, NOP58,
ALG11, FTSJ2, NSUN2
GOTERM_BP_FAT GO:0042254 ~ ribosome biogenesis 6 2.17 4.59E-2 WDR55, TSR1, NOLC1, NOP58, ALG11, FTSJ2
Annotation Cluster 5
Enrichment Score: 1.68
GOTERM_BP_FAT GO:0006399 ~ tRNA metabolic process 8 2.90 2.83E-3 TRNT1, IARS, METTL1, ADAT2, GARS, EPRS, NSUN2,
MARS
GOTERM_BP_FAT GO:0043039 ~ tRNA aminoacylation 4 1.45 3.69E-2 IARS, GARS, EPRS, MARS
GOTERM_BP_FAT GO:0043038 ~ amino acid activation 4 1.45 3.69E-2 IARS, GARS, EPRS, MARS
GOTERM_BP_FAT GO:0006418 ~ tRNA aminoacylation for
protein translation
4 1.45 3.69E-2 IARS, GARS, EPRS, MARS
Annotation Cluster 6
Enrichment Score: 1.43
GOTERM_BP_FAT GO:0016192 ~ vesicle-mediated transport 20 7.25 2.23E-3 CAV2, RAB2B, LDLR, CNIH, VPS45, GARS, RER1, SNX4,
AP4S1, RAB1A, COPB2, AP1S1, TFRC, CDC42SE2,
ACTR1A, PIKFYVE, RAB22A, VPS4A, TRAPPC3, ZW10
GOTERM_BP_FAT GO:0016044 ~membrane organization 12 4.35 4.24E-2 CAV2, COPB2, AP1S1, DNM1L, LDLR, TFRC, CDC42SE2,
FXC1, RAB22A, PIKFYVE, SNX4, TIMM8A
Table 5 Real-time PCR confirmation of the microarray results
Microarray qPCR
Gene VE vs CON VE vs CON
L.Thoracis
CISH −2.05*** −3.07**
ABCC4 −1.22*** −1.07
ACAT1 −1.25*** −1.42
IGF1R −1.17** −1.03
Subcutaneous fat
LDLR 2.66**** 2.25
METLL1 1.53**** 1.28
SOD3 −2.78**** −3.51**
SQLE 2.70**** 2.24
SREBF1 1.76**** 1.73
HAX1 1.44**** 1.21
HMGB2 −1.53**** −2.24
HSPB8 1.87**** 1.86
IER3 −2.06**** −2.54*
Gene expression changes in L. Thoracis muscle (CISH, ABCC4, ACAT1 and IGF1R)
and subcutaneous fat (LDLR, SOD3, SQLE, SREBF1, HAX1, METLL1, HMGB2, HSPB8
and IER3) by the fold change (FC) obtained with microarray and qPCR data
and their significance (P < 0.1*; P < 0.05**; P < 0.01***; P < 0.001****)
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expression of 29 genes in the LT muscle. The results of
functional analysis showed that genes related to the intra-
cellular signaling cascade (CISH, IGF1R, DEF8, and
AKAP7) and metabolic processes (ZNF79, MAFB, MYLK2,
ACACB, ACAT1, CISH, IGF1R, PGLS, DUSP26, AKR7A2,
FBXL4, AKAP7, and RSC1A1) were down-regulated. The
enrichment scores were less than 1.3, likely because the
number of significant genes in this contrast was low. The
most down-regulated gene by vitamin E in LT was CISH
(Cytokine Inducible SH2 containing protein). Chen et al.
[24] reported that CISH activates protein kinase C (PKC)
activity by G-protein coupled receptor protein, which is
important for the activation of both the activator protein 1
(AP-1) and nuclear factor- κB (NF-κB) pathways. In a pre-
vious study Boscoboinik et al. [25], demonstrated that PKC
is inhibited by α-tocopherol. NF-κB proteins are a fam-
ily of transcription factors and are of central import-
ance in inflammation, immunity and apoptosis [26].
Evidence suggests a role for reactive oxidative intermedi-
ates (ROIs) as a common and critical intermediate for
various NF-κB-activating signals, based on inhibition of
NF-κB activation by a variety of antioxidants [27, 28].
There is a bidirectional relationship between cytokines
and oxidative stress. Exposure of myotubes to reactive
oxygen species (ROS)-producing agents resulted in an in-
crease in interleukin 6 (IL-6) release through the activa-
tion of the redox-sensitive transcription factor, NF-κB
[28]. In this sense, IL-6 induces marked increases in
expression of CISH, SOCS-1, SOCS-2, and SOCS-3 in tis-
sues, which in turn result in inhibition of the signaling of
wide range of cytokines [29]. Thus, CISH expression could
be related to oxidative status in the muscle. In this sense,
low levels of ROS and ROIs in muscle caused by α-
tocopherol could be associated with low expression of
CISH. In this sense, lipid oxidation in the LT muscle and
metmyoglobin formation were lower when lambs were
supplemented with VE. In the same manner, RSC1A,
which inhibits a dynamin and PKC-dependent exocytotic
pathway of SLC5A1 gene, was down-regulated in the VE
group. Interestingly enough CISH and MYLK, also down-
regulated in the VE treatment, are involved in
inflammation mediated by chemokine and cytokines
signaling pathway, which could suggest another possible
role for VE that of decreased inflammation.
In our study, alterations of the Ras homolog gene family,
member A (RhoA) and actin cytoskeleton signaling were
identified (IGF1R and MYLK2 genes). Both IGF1R and
MYLK2 were down-regulated in VE treatment. Insulin-
like growth hormone 1 (IGF-1) is a protein structurally
similar to insulin, and it regulates tissue growth and
development in several vertebrates [30]. As a main re-
ceptor of IGFs, IGF1R mediates the transduction of
metabolic signals of cell proliferation, bone growth, and
protein synthesis in the GH/IGF pathway [31]. In our
study, IGF1R was down-regulated in VE treatment, and
because of IGF1R polymorphisms have been associated
to growth traits [32–36], we thought that this effect
could be due to the higher ADG in CON animals.
However, ADG values were included as a covariate in
the statistical model used to validate expression differ-
ences by qPCR, thus avoiding estimation biases related
to ADG. Therefore these results suggest that supple-
mentation with VE causes down-regulation of IGF1R in
LT muscle. Our findings are in agreement with Araujo
et al. [37], who showed that VE supplementation re-
duces IGF1R expression by 17% in hyperthyroid of
Wistar rats. In addition, Chuang et al. [38] also found
that VE alone significantly and dose-dependently reduced
the cell surface expression of IGFIR in HL-60 cells. More-
over, Holzenberger et al. [39] reported that Igf1r+/−mice
display greater resistance to oxidative stress.
In addition, vitamin E down-regulated two genes related
to lipid metabolisms (ACAT1 and ACACB) in the LT
muscle. ACAT1 (acetyl-coenzyme A acetyltransferase 1) en-
codes a mitochondrial localized enzyme that catalyzes the
reversible formation of acetoacetyl- CoA from two mole-
cules of acetyl-CoA. ACAT1 is responsible for cholesterol
homeostasis and maintain appropriate cholesterol availabil-
ity in cell membranes, whereas ACACB is the key regulator
of the fatty acid oxidation pathways [40]. It controls fatty
acid oxidation by means of the ability of malonyl-CoA to
inhibit carnitine-palmitoyl-CoA transferase I (CPT1B). As
in our work, Shige et al. [41] showed that vitamin E re-
duced the uptake of modified low-density lipoprotein
(LDL) and suppressed ACAT activity, resulting in less chol-
esterol esterification in macrophages. Interestingly enough
ABCC4, an ATP-binding cassette (ABC) transporter,
AKR7A2 which is involved in the detoxification of alde-
hydes and ketones, and finally RSC1A1 which transport
carbohydrate across the plasma membrane, were all down-
regulated with VE treatment. In hepatocytes, ABCC4 was
shown to be induced by oxidative stress through binding of
the oxidative sensor nuclear factor E2-related factor 2
(Nrf2) to antioxidant-responsive element sequences in the
promoter of ABCC4 [42]. Our results showed for the first
time that vitamin E down-regulates ABCC4 expression. Be-
cause of significant differences in ADG between treatments,
we validated the expression results of the CISH, ABCC4,
ACAT1 and IGFR1 genes by qPCR, including in the statis-
tical model ADG as a covariate. ADG was not significant,
with a similar FC between the microarray and qPCR results
(r2 = 0.99; P = 0.008). Therefore, treatment was the main ef-
fect over gene expression.
In addition, we found that the transcription factors
FHL3, ZNF777 and MAFB were down-regulated. Con-
sidering all together, our results showed that supplemen-
tation with VE increased the content of α-tocopherol in
the LT muscle and decreased metmyoglobin formation
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and lipid oxidation. We speculate that α-tocopherol in
the LT muscle causes a decrease in the catalytic activity
of enzymes involved in cellular transport of fatty acids
and carbohydrates, and fatty acid oxidation in the mito-
chondria. Decreased IGF1R expression might be related
to the lower lipid oxidation levels in VE animals. We
also found that IGFR1, ABCC4 ACAT1, CISH, ACACB,
MYLK2, ZNF777 and MAFB were positively correlated
with each other and with the diet, which suggest co-
expression processes of these genes. We speculate that
transcription factors ZNF777, MAFB and FHL3 could be
important players in mediating the effects of VE in regu-
lating the expression of these genes.
To establish whether IGFR1, ABCC4 and ACAT1,
CISH are markers of meat oxidation or indirect markers
of meat quality, further studies with greater numbers of
animals are necessary.
A most dramatic effect of VE was observed on SF gene
expression. ALG11, SRPBR, DDX47, SEC23ID and TTC37
were among the most important genes in discriminate fed
treatments. These genes were up-regulated and positively
correlated with each other and with the diet, which might
suggest co-expression processes. Four of the up-regulated
genes in the VE group were related to heat shock proteins
(HSPs) or chaperonin activity (TTC37, DNAJC16, HSB8,
AHSA1). Some HSPs are characterized by various specific
functions such as anti-apoptotic or anti-inflammatory ef-
fects [43]. In our study, these genes were up-regulated and
positively correlated, suggesting putative increased stress
protection in VE lambs.
Surprisingly VE treatment showed general up-regulation
of almost all significant genes, compared to CON treat-
ment. Lipid biosynthetic processes were among the
most enriched functional clusters with major biological
significance and importance (PGAP3, EBP, CRLS1,
MVD, CYP51A1, GNE, HMGCS1, DPAGT1, LSS,
SIGMAR1, LPCAT3, FDFT1, DOLK, PIGM, SQLE,
DHCR7, AGPAT9, LTA4H, PCYT2, and HSD17B7).
Moreover, genes implicated in sterol, steroid and chol-
esterol biosynthesis processes (SREBF1, EBP, LDLR,
MVD, CYP51A1, SQLE, DHCR7, INSIG1, HMGCS1,
LSS, and FDFT1) were up-regulated in the SF of VE
animals, compared to the CON group. It has been
previously reported that tocopherols inhibited de novo
cholesterol synthesis within enterocytes [44], and cause
repression of genes (DHCR7 and HMGCS1) involved in
the de novo synthesis of cholesterol in testes and ad-
renal glands [45]. The differences reported in previous
studies and ours might be due to the different tissues
analyzed. This supports even more our idea that there
is a tissue specific response in response to VE supple-
mentation. On the other hand, Wang et al. [46] found
oxysterol-specific repressive effects in the CYP51A1
and FDFT1 genes, mediated via direct binding of the
ligands to liver X receptor (LXR). Because of α–tocoph-
erol and other antioxidants can inhibit the oxidation of
cholesterol [47], the VE group could have a lower quantity
of oxysterols and then have inhibited the repression of
cholesterol biosynthesis via LXR and oxysterols and up-
regulated the sterol, steroid and cholesterol biosynthesis
processes. In this sense, several genes implicated in “the
stress response” (SOD3, IER3, HMGB2, UACA, LUC7L3)
were down-regulated in the VE group, compared to the
CON group (Table 3 and Supplementary Table S1).
Among them, SOD3 showed higher values of FC. This
gene encodes a member of the superoxide dismutase
(SOD) protein family that protects the extracellular space
from the toxic effects of reactive oxygen intermediates by
converting superoxide radicals into hydrogen peroxide
and oxygen. This finding contradicts the results of previ-
ous studies, which suggested that grass-based treatments
elevated the activity of antioxidants, such as glutathione
and superoxide dismutase (SOD), compared to grain-
feeding [1]. However, Kumar et al. [48] in the myocardium
muscle and Strobel et al. [49] in the skeletal muscle of
exercise-trained and sedentary rats, found that antioxidant
supplements reduced the endogenous antioxidants SOD2
gene and protein and the glutathione peroxidase (GPx)
gene and enzyme activity.
Another down-regulated gene in VE treatment was
IER3. IER3-deficient NCM460 cells exhibited reduced
reactive oxygen species levels, indicating increased anti-
oxidative protection [50]. In our study, IER3 was down
regulated in the VE group suggesting an increase in anti-
oxidative protection. The role of HMGB1 in recognizing
aberrant or damaged DNA has been shown in multiple
in vitro experiments. A recent study directly showed the
accumulation of HMGB1 at sites of oxidative DNA dam-
age in live cells, thus defining HMGB1 as a component
of an early DNA damage response [51]. A similar func-
tion has been attributed to HMGB2 [52]. These authors
hypothesized that HMGB1/2 proteins act as a sensor of
DNA modification, and their interaction with chemically
altered DNA changes the chromatin structure, thus in-
ducing DNA damage responses.
Finally, a cluster related to tRNA metabolic processes
was also significant (TRNT1, METTL1, ADAT2, NSUN2,
IARS, GARS, EPRS and MARS). Aminoacyl-tRNA synthe-
tases perform an essential function in protein synthesis by
catalyzing the esterification of an amino acid to its cognate
tRNA (IARS, GARS, EPRS and MARS). Considering all to-
gether, we speculate that in the SF, vitamin E exerts anti-
inflammatory effect and stress protection by increasing
heat shock protein expression. Vitamin E reduces stress
response probably as results of reduced reactive oxygen
species levels. In addition animals supplemented with VE
might have inhibited cholesterol oxidation in SF and
enhanced sterol, steroid and cholesterol biosynthesis
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processes. And finally, we speculate that regulation of
these gene expressions it could be mediated through
tRNAs IARS, GARS, EPRS andMARS.
Regarding LT, we included ADG values as a covariate
in the statistical model used to validate the expression
differences by qPCR to avoid estimation biases. In this
case, ADG was not significant, and a similar FC be-
tween microarray and qPCR results was found (r2 =
0.99; p < 0.0001). Thus, the treatment was also the main
effect over gene expression of SF.
Although we found differences in mRNA activity, it did
not necessarily cause differences in metabolic processes. An
increase in gene expression is not necessarily correlated
with an increase in protein concentrations or enzyme activ-
ities. There are many processes between transcription and
translation, including post-transcriptional, translational
and protein degradation regulation, in controlling
steady-state protein abundances [53]. Moreover, DNA
microarray has been the technology of choice for tran-
scriptome analysis in recent years. Nonetheless, array
technology has several limitations which include: using
microarray technology limits the researcher to detect-
ing transcripts that correspond to existing genomic se-
quencing information; and background hybridization
limits the accuracy of expression measurements, par-
ticularly for transcripts present in low abundance.
Conclusion
This study demonstrated the beneficial effects of vitamin
E supplementation during fattening period in lambs by in-
creasing α-tocopherol content in the LT muscle and
diminishing drastically the lipid oxidation of the meat. We
observed a tissue-specific response to vitamin E supple-
mentation. The gene expression profiles for VE and CON
treatments were different in both LT and SF. Vitamin E
supplementation had a dramatic effect on subcutaneous
fat gene expression, showing a general up-regulation of
genes, compared to CON treatment. Our study enabled
us to identify novel genes (for example, IGF1R, ACAT1,
ABCC4, ACACB, SOD3, and IER3) and metabolic path-
ways related to vitamin E metabolism that might be impli-
cated in meat quality. To the best of our knowledge, this
study was the first to report the effect of vitamin E supple-
mentation on gene expression in the LT muscle and SF of
lambs. Future exploration of these genes is necessary for a
better understanding of how vitamin E affects the oxida-
tive processes that occur in meat products.
Methods
Ethics statement
All experimental procedures including the care of ani-
mals and euthanasia were performed in accordance with
the guidelines of the European Union and with Spanish
regulations for the use and care of animals in research
and were approved by the Animal Welfare Committee
of the Centro de Investigación y Tecnología agroalimen-
taria (CITA) (protocol number 2009-01_MJT). In all
cases, euthanasia was performed by penetrating captive
bolt followed by immediate exsanguination.
Animals and sample collection
Fourteen single reared male lambs of the Rasa Aragonesa
breed were weaned at 48.28 ± 0.85 days of age. Seven
lambs were fed a basal concentrate from weaning to
slaughter (CON treatment, 24 ± 2.62 days). The remaining
7 lambs received for 4.71 ± 2.62 days the same basal con-
centrate as the CON group, and thereafter until slaughter,
they received a similar concentrate with the same charac-
teristics but enriched with 500 mg dl-α-tocopheryl acetate
per kg of feed (VE treatment) for 33.28 ± 1.07 days. The
ingredients and chemical composition of the feedstuffs are
shown in Table 6. Prior to weaning, the CON and VE
lambs suckled their mothers and had free access to their
concentrates. The average concentrate intake of the CON
and VE lambs during the experimental period was 24.3
and 25.1 kg per lamb, respectively. The experimental pro-
cedures, management of the animals and sample details
for each group are described in detail in Ripoll et al. [11].
All of the lambs were slaughtered when they attained
22–24 kg of slaughter weight (SW), according to the speci-
fications of Ternasco de Aragón Protected Geographical In-
dication (Regulation (EC) No. 1107/96), which stipulates
that lambs must be less than 90 days old with a SW
between 22 and 24 kg. The lambs were slaughtered using
Table 6 Ingredients and chemical composition of the feedstuffs
used in the experiment
Item CON concentrate VE concentratea
Ingredients (%)
Barley 40.87 40.87
Corn 14.95 14.95
Wheat 20.08 20.08
Soyabean meal 19.78 19.78
Salt 0.39 0.39
Carbonate 1.64 1.64
Mineral-vitamin mixture 1.20 1.10
Fat 1 1
Chemical composition
CP, g/kg DM 175 175
NDF, g/kg DM 180 180
ADF, g/kg DM 45 45
α-tocopherol, mg/kg DM 27b 480b
DM, dry matter; CP, crude protein; NDF, neutral detergent fibre; ADF, acid
detergent fibre
aCommercial concentrate enriched with vitamin E (Corderos Alendi Vitamina E-
500, Ars Alendi S.A, Huesca, Spain). bas mg dl-α-tocopheryl acetate/kg DM
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EU laws in the same commercial abattoir, and the carcasses
were hung by the Achilles tendon and chilled for 24 h at 4 °
C in total darkness. The slaughter age, slaughter weight,
and growth rate of the 2 management strategies are pre-
sented in Table 1.
Immediately after slaughter, a piece of LT muscle
from the 12th thoracic vertebra and a piece of SF be-
tween the atlas and axis cervical vertebrae were cut,
frozen in liquid nitrogen and stored at−80 °C until
RNA isolation.
Analysis of α-tocopherol, intramuscular fat content,
TBARS and metmyoglobin formation
After chilling, a piece of the LT muscle between the 4th
and the 6th lumbar vertebrae was vacuum-packed and
kept at−20 °C in darkness until the α-tocopherol ana-
lysis. The α-tocopherol concentration was determined
by liquid extraction as described in González-Calvo et al.
[54]. A portion of the loin between the 7th and the 13th
thoracic vertebrae was used to measure the LT muscle
oxidative processes. The color (metmyoglobin content,
MMb) and lipid oxidation analysis (thiobarbituric acid-
reactive substance, TBARS) were quantified after 7 days
of being maintained in darkness at 4 °C. The LT muscle
color and LT intramuscular fat oxidation were measured
as described in González-Calvo et al. [54]. Briefly, the
relative content of metmyoglobin (MMb) was estimated
by the K/S572/525 ratio [55]. This ratio decreases when
the MMb content increases. Intramuscular fat oxidation
of the M. Longissimus thoracis was determined using the
procedure reported by Pfalzgraf et al. [56]. The TBARS
values are expressed as milligrams of malonaldehyde
(MDA) kilogram−1 of muscle.
RNA isolation and assessment of RNA integrity
Total RNA was extracted from approximately 500 mg of
LT muscle or SF using RNeasy Tissue mini kits (QIAGEN,
Madrid, Spain), following the manufacturer’s protocol.
Prior to microarray analysis, RNA integrity and quality
were assessed by a RNA 6000 Nano LabChip on the
Agilent 2100 Bioanalyzer (Agilent, Madrid, Spain) and
were quantified using a nanophotometric spectrophotom-
eter (Implen, Madrid, Spain). All RNA integrity number
(RIN) values were greater than 8.
Microarray hybridization and data processing
RNA samples (n = 14, 7 samples from each treatment) were
analyzed using Ovine Gene 1.1 ST Array Strip (Affymetrix,
High Wycombe, UK). The Ovine gene 1.1 ST Array Strip
allows for processing of four samples in parallel. This array
contains a collection of 508538 probes that interrogate up
to 26 unique sequences of each transcript (median probes/
transcript = 23). These probes correspond to 22047 ovine
genes. This study was part of a larger study in which we an-
alyzed 84 samples corresponding to 3 treatments and 4 tis-
sues (7 animals per treatment). In each strip, we hybridized
the four tissues, selecting the animal tissue for each strip by
random sampling. Microarray hybridization and scanning
were performed at the Functional Genomics Core fa-
cility (Institute for Research in Biomedicine, IRB Bar-
celona, Spain), following the recommendations of the
manufacturer. Scanned images (DAT files) were trans-
formed into intensities (CEL files) by Affymetrix Gene-
Chip Operating Software (GCOS). Overall array
intensity was normalized between arrays to correct for
systematic bias in the data and to remove the impact
of non-biological influences on biological data. The
imported data were analyzed at the gene-level, with
exons summarized to genes, using the mean expression
of all of the exons of a gene. Normalization was per-
formed with the Robust Multi-Array Average (RMA)
algorithm using quantile normalization, median polish
probe summarization, and log2 probe transformation.
The data sets supporting the results and discussed in
this publication have been deposited in NCBI’s Gene
Expression Omnibus repository [57] and are accessible
through GEO Series accession number GSE63774
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE63774? acc = GSE63774).
Validation of microarray data by qPCR
One microgram of RNA from each sample were treated
with DNAse (Invitrogen, Carlsbad, CA, USA), and
single-stranded cDNA was synthesized using the Super-
Script®III Reverse Transcriptase kit (Invitrogen, Carlsbad,
CA, USA), following the manufacturer’s recommenda-
tions. Specific exon-spanning primers for genes were
generated and confirmed for specificity using BLAST
(National Center for Biotechnology Information: http://
www.ncbi.nlm.nih.gov/BLAST/). Before performing the
qPCR reactions,conventional PCR was performed for all
of the genes to test the primers and to verify the ampli-
fied products. The PCR products were sequenced to
confirm gene identity using an ABI Prism 3700 (Applied
Biosystems) with standard protocols. Homology searches
were performed with BLAST (National Center for Biotech-
nology Information: https://blast.ncbi.nlm.nih.gov/Blas-
t.cgi) to confirm the identity of the amplified
fragments. Quantitative reverse transcriptase polymer-
ase chain reaction (qRT-PCR) was performed using
SYBR Green Master Mix: SYBR Premix Ex Taq II (Tli
RNase H Plus) and an ABI Prism 7500 platform (Ap-
plied Biosystem, Madrid, Spain). Standard curves for
each gene were generated to calculate the amplification
efficiency through 4-fold serial dilution of cDNA
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pooled from the LT muscle and SF. The efficiency of
PCR amplification for each gene was calculated using
the standard curve method (E = 10(−1/slope)). Two “con-
nector samples” were replicated in all of the plates to re-
move technical variation from this source of variability.
The annealing temperatures, primer concentrations,
and primer sequences for CISH, ABCC4, ACAT1,
IGF1R, LDLR, SQLE, SREBF1, SOD3, HAX1, HMGB2,
METTL1, HSPB8, and IER3 (genes of interest: GOIs)
and the reference genes (GUSB and YWHAZ) are de-
scribed in Table 7. These reference genes were chosen
because in previous studies they have been shown to be
the most stable in these tissues [5].
Statistical analysis
Statistical analysis of performance, α-tocopherol and lipid
oxidation in the LT muscle
Statistical analysis was performed using a general lineal
model (GLM). Treatment (CON and VE) was included as
the fixed factor for weaning age (WA), slaughter age (SA),
slaughter weight, intramuscular fat content (IMF) and
average daily gain (ADG). For muscle α-tocopherol, myo-
globin and TBARS, the model also included intramuscular
fat content and slaughter age as covariates. The results are
expressed as least square means ± the standard error (SE)
values and the differences were tested at a level of signifi-
cance of 0.05 with the t statistic.
Table 7 Primers forward and reverse used in RT-PCR
PCR conditionsa
Symbol Gene Primers forward and reverse Amplicon bp AT nM E R2
CISH Cytokine inducible SH2-containing protein F:5′-agccaagaccttctcctacct-3′ 96 60 600/600 1.98 0.99
R:5′-acgaggaagacagtgaagacg-3′
ABCC4 ATP-binding cassette, sub-family C (CFTR/MRP),
member 4
F: 5′-ccgtgagaaatttgcccactg-3′ 128 60 900/900 2.00 0.99
R: 5′- gcaaaacatacggctcatcat-3′
ACAT1 A cetyl-Coenzyme A acetyltransferase 1 F: 5′-gagctgtttctcttggacatcc-3′ 118 60 900/900 1.98 0.99
R: 5′- cctcctcctccgttgcaaat-3′
IGF1R Insulin-like growth factor 1 receptor F: 5′-ccaaggcctgagaactccat-3′ 122 60 900/900 2.00 0.98
R: 5′- ctggacacacattcccgct-3′
LDLR Low density lipoprotein receptor F:5′- gcatcaacttcgacaaccct -3′ 112 60 600/600 2.00 0.98
R:5′- tcctccaagctgaccatctg -3′
SQLE Squalene epoxidase F:5′-aatgtgttgcaggtccggtt-3′ 88 60 600/600 1.98 0.98
R:5′- tagactgcgacgccaaagaa -3′
SREBF1 Sterol regulatory element binding transcription
factor 1
F:5′- ctgctatgcaggcagcac -3′ 99 60 200/200 2.00 0.98
R:5′- ggttgatgggcagcttgt -3′
SOD3 Superoxide dismutase 3, extracellular F:5′-atccacgtgcaccagtttg-3′ 110 60 300/300 2.00 0.98
R:5′-aagttgccaaagtcgccc-3′
HAX1 HCLS1 associated protein X-1 F:5′-taacccatcaagaggcaggc-3′ 115 60 600/600 1.99 0.99
R:5′-gaccggaaccaacgtcctag-3′
HMGB2 High-mobility group box 2 F:5′-gccgtatgaacagaaagcagc-3′ 126 60 600/600 1.94 0.99
R:5′-ttcttcttggagcctgtcgg-3′
HSPB8 Heat shock 22 kDa protein 8 F:5′-agcaagaaggtggcatcgtt-3′ 126 60 400/400 2.00 0.99
R:5′- cctggggagcttcgatgatc-3′
IER3 Immediate early response 3 F:5′-ttcaccttcgaccctctccc-3′ 130 60 400/400 1.90 0.97
R:5′- cctcgactggcagctgac-3′
METTL1 Methyltransferase like 1 F:5′-ggagctgcatgagtggatgt-3′ 104 60 600/600 1.97 0.99
R:5′- tgcccagatgtcccacaatg-3′
GUSB β-glucuronidase F:5′-gcttcgagcagcagtggta-3′ 86 60 600/600 1.99 0.99
R:5′-cacgtcgttgaagctggac-3′
YWHAZ Tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein
F:5′- tgtaggagcccgtaggtcatct-3′ 102 60 400/400 1.99 0.98
R:5′ - ttctctctgtattctcgagccatct-3
aReal-time PCR conditions: annealing temperature (AT), primer concentrations (nM), E: primer efficiency and R2: correlation coefficient
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Statistical analysis for the identification of differentially
expressed genes by microarray analysis in LT and SF
Normalized data were further analyzed using Babelomics
(http://babelomics.bioinfo.cipf.es/) and MetaboAnalyst
software [58]. Genes showing a statistically significant
value of the Limma-test; (P < 0.01) were screened out as
differentially expressed between the treatments. Signifi-
cant genes were annotated based on similarity scores in
blastn comparisons of Affymetrix Transcript cluster se-
quences against ovine sequences in GenBank. In addition,
a second method, significance analysis of microarray
(SAM), was used to identify and reconfirm differentially
expressed genes in VE-CON contrasts. Furthermore,
SAM was used to detect false positive significant genes
from Limma-testing. SAM is a well-established statistical
method for the identification of differentially expressed
genes in microarray data analysis [58]. SAM is designed to
address the FDR when running multiple tests on high-
dimensional microarray data. First, it assigns a significance
score to each variable based on its relative change from
the standard deviation of repeated measurements. Then, it
chooses variables with scores greater than an adjustable
threshold Δ and compares their relative differences from
the distribution estimated by random permutations of the
class labels. For each Δ, a certain proportion of the vari-
ables in the permutation set will be found to be significant
by chance. This number is used to calculate the FDR.
Underestimation of the variability inflates the value of the
statistic and can result in an increased number of false
positives.
Multivariate analysis of gene expression
Multivariate analysis was performed using MetaboAnalyst,
according to Xia et al. [58]. Principal component analysis
(PCA), partial least squares discriminate analysis (PLS-
DA), and variable importance of projection (VIP) were
used to cluster the samples based on the selected gene ex-
pression profiles. Principal component analysis was used
to reduce the large set of variables (genes) into 2 principal
components (PCA 1 and 2). PLS-DA was used to enhance
the separation between the groups by summarizing the
data into a few latent variables that maximized covariance
between the response and the predictors. The correspond-
ing loading plot was used to determine the genes most re-
sponsible for separation in the PLS-DA score plot. Based
on the PLS-DA results, genes were plotted according to
their importance in separating the dietary groups and each
gene received a value called the variable importance in the
projection. Variable importance in the projection values
>1 suggests that the variable is significantly involved in
the separation of groups [59]. Variables with the highest
VIP values were the most powerful group of discrimina-
tors. We also investigated trends or patterns in gene ex-
pression changes.
Hierarchical clustering analysis (HCA)
Cluster analysis was performed using MetaboAnalyst. In
(agglomerative) hierarchical cluster analysis, each sample
begins as a separate cluster and the algorithm proceeds to
combine them until all of the samples belong to one clus-
ter. Two parameters must be considered when performing
hierarchical clustering. The first is the similarity measure,
and the other is the clustering algorithm. For distance
measurements we used the Euclidian and Ward algorithm
for clustering. The results are shown as a heatmap.
Statistical analysis of gene expression validated by qPCR
The corresponding mRNA levels were measured and an-
alyzed by their quantification cycles (Cq). The statistical
methods to analyze differences in the expression rate
were performed following the method proposed by Steibel
et al. [60]. The mixed model fitted was:
yrigkm¼TGgi þ b IMFð Þm þ b ADGð Þm þ Pk þ Am þ erigkm
where, yrigkm is the Cq value (transformed data taking
into account E < 2) of the gth gene (GOIs and house-
keeping) from the rth well in the kth plate collected from
the mth animal subjected to the ith treatment (CON, VE
and ALF); TGgi is the fixed interaction among the i
th
treatment and the gth gene; IMFm (only used in L.
Thoracis muscle tissue gene expression), and ADGm are
the effects of intramuscular fat, and the average daily
gain of the mth animal included as covariates; Pk is the
fixed effect of the kth plate; Am is the random effect of
the mth animal from which samples were collected
(Am ~ (0,σ
2
A)); and erigkm is the random residual. Gene
specific residual variance (heterogeneous residual) was
fitted to the gene by treatment effect (erigkm~N (0, σ
2
egi).
To test differences (diffGOI) in the expression rates of
the target genes between treatments in terms of fold
changes (FCs), the approach suggested by Steibel et al.
[60] was used. The significance of the diffGOI estimates
was determined with the t statistic.
Functional annotation analyses
The Database for Annotation, Visualization and Integrated
Discovery (DAVID) v6.7b [61], was used to determine the
pathways and processes of major biological significance
and importance through the Functional Annotation
Cluster (FAC) tool based on the Gene Ontology (GO)
annotation function. DAVID FAC analysis was performed
with the gene lists obtained after SAM analysis. Medium
stringency EASE score parameters were selected to indi-
cate confident enrichment scores of functional signifi-
cance and the importance of the given pathways and
processes investigated. An enrichment score of 1.3 was
employed as a threshold for cluster significance [61].
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